1. Regarding thyroid nodule management, the authors state that thyroid fine needle aspiration (FNA) cytology should be performed ''when nodule bigger than 1 cm and/or low TSH…'' On the contrary, in the initial evaluation of a patient with a thyroid nodule, if the serum TSH is low, a radioactive iodide (RAI) thyroid scan should be performed prior to FNA to document whether the nodule is hyperfunctioning or not. Since hyperfunctioning nodules are rarely malignant, if one is found that corresponds to the nodule in question, no cytological evaluation is necessary. Finally, it is our intention to be constructive and all of our suggestions are based on the recent and comprehensive Revised American Thyroid Association Guidelines for the management for Thyroid Nodules and Differentiated Thyroid Cancers published in 2009 as well as on the Consensus Guidelines of the European Thyroid Association published in 2006 [3, 4] . Controversy still exists in some areas including the most appropriate approach for the diagnostic evaluation of a thyroid nodule, the extent of surgery for microcarcinomas and the use of RAI to ablate remnant tissue following thyroidectomy among others. As new advances appear in the future, we hope new clinical guidelines using principles of evidence-based medicine will improve the optimal care for patients with thyroid cancer.
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